Business Context and Reporting Period
This Form 8-K, filed on April 2, 2019, reports the completion of the separation of Dow Inc. from DowDuPont Inc. effective April 1, 2019. The separation was executed via a pro rata distribution of Dow common stock to DowDuPont shareholders of record as of March 21, 2019. Dow is now an independent, publicly traded company listed on the New York Stock Exchange under the symbol "DOW" and serves as the successor issuer to The Dow Chemical Company (TDCC).
Key Financial Metrics
This filing is a current report regarding corporate events and does not contain audited revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The filing references unaudited pro forma combined financial information for TDCC (Exhibit 99.2) which reflects the separation transactions, but specific numerical values for these metrics are not provided in the text of this document.
Material Changes Versus Prior Period
- Corporate Structure: Dow transitioned from a wholly-owned subsidiary of DowDuPont to an independent, publicly traded entity.
- Ownership: DowDuPont now holds no ownership interest in Dow.
- Board Composition: The Board of Directors expanded from three to ten members. Howard I. Ungerleider resigned, and eight new directors were appointed, including Jeff M. Fettig as non-executive Chairman.
- Executive Leadership: James R. Fitterling continues as CEO and Howard I. Ungerleider as President and CFO. Five new executive officers were appointed, including Karen S. Carter (CHRO) and Amy E. Wilson (General Counsel).
- Legal Framework: The Certificate of Incorporation and Bylaws were amended and restated effective April 1, 2019.
Guidance, Outlook, and Material Agreements
The filing does not provide forward-looking financial guidance or management commentary on future performance. However, it details the entry into several material definitive agreements effective April 1, 2019, including:
- Separation and Distribution Agreement
- Tax Matters Agreement
- Employee Matters Agreement
- Intellectual Property Cross-License Agreements (with DowDuPont and Corteva, Inc.)
Additionally, the Board adopted new Corporate Governance Guidelines, a Code of Conduct, and a Code of Financial Ethics. The filing notes the voluntary submission of unaudited pro forma financial information reflecting the disposition of specialty and agriculture businesses and the acquisition of ethylene and ethylene copolymers businesses.
Investor Verification Checklist
- Verify the terms of the Separation and Distribution Agreement (Exhibit 2.1) regarding ongoing liabilities and asset transfers.
- Review the unaudited pro forma combined financial information (Exhibit 99.2) to understand the financial impact of the separation and the ECP Acquisition.
- Confirm the details of the Intellectual Property Cross-License Agreements (Exhibits 10.3 and 10.4) to assess potential licensing costs or restrictions.
- Examine the Tax Matters Agreement (Exhibit 10.1) for potential tax liabilities or indemnification obligations.
- Review the Amended and Restated Certificate of Incorporation and Bylaws (Exhibits 3.1 and 3.2) for changes in shareholder rights or governance structures.